Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)

Abroad (travel likely)Recruiting

Conditions

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) · Chronic Rhinosinusitis (CRS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Onze Lieve Vrouw hospital Aalst, Aalst, Belgium

    Contact: Study coordinator (Principal investigator Dr. Benedicte Verhaeghe, MD) · b.verhaeghe@yahoo.com · +3253728524
  • General hospital Sint-Jan Bruges, Bruges, Belgium

    Contact: Study coordinator (Principal Investigator Dr. K. Speleman, MD) · kato.speleman@azsintjan.be · +3250 45 22 80
  • University hospital Saint-Luc, Brussels, Belgium

    Contact: Study coordinator (Principal investigator Prof. Valérie Hox, MD-PhD) · valerie.hox@saintluc.uclouvain.be · +322 764 19 42
  • University hospital of Antwerp, Edegem, Belgium

    Contact: Study coordinator (Principal investigator prof. Olivier Vanderveken, MD-PhD) · olivier.vanderveken@uza.be · +32 3 821 30 00
    Anneclaire Vroegop, MD-PhD (Sub-investigator)
  • Hospital Zuid-Oost Limburg, Genk, Belgium

    Contact: Study coordinator (Principal Investigator Dr. W. Lemmens, MD) · winde.lemmens@zol.be · +3289/32.50.50
  • University Hospital Brussels, Jette, Belgium

    Contact: Study coordinator (Principal investigator Dr. Stijn Halewyck, MD) · stijn.halewyck@uzbrussel.be · +322 477 60 02
  • University hospitals Leuven, Leuven, Belgium

    Contact: Study coordinator (Elien Borgers, MSc) · elien.borgers@uzleuven.be · +3216/34.20.37
    Contact: Principal Investigator (Peter Hellings, MD-PhD)
    Laura Van Gerven, Md-PhD (Sub-investigator)
    Mark Jorissen, MD-PhD (Sub-investigator)
    An-Sofie Viskens, MD (Sub-investigator)
  • CHU de Liège, Liège, Belgium

    Contact: Study coordinator (Séverine Camby) · s.camby@chuliege.be · +32474415961
    Contact: Principal Investigator (Florence Rogister, MD)
Study leads
  • Peter Hellings, MD,PhD

    Principal Investigator

    Universitaire Ziekenhuizen KU Leuven